Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Why Big Tech is offering Biden help with COVID-19 vaccination

By Brian Buntz | February 17, 2021

Biden

[Joe Biden photo from Wikipedia]

Big Tech is apparently viewing the COVID-19 pandemic as a means to improve its standing with the public and the Biden administration.

Amazon (NSDQ:AMZN) has offered to help with vaccine distribution. Google (NSDQ:GOOG) plans to use some of its U.S. properties as vaccination sites and offering free ad space to public health officials. Airbnb (NSDQ:ABNB) wants to establish “vaccine depots” in areas with poor healthcare access, wrote Christopher Lehane, the company’s senior vice president for global policy and communications, in a letter to HHS. Facebook has offered to donate $120 million to public health agencies and vowed to crack down on vaccine misinformation.

As companies like Amazon offers to streamline the vaccine logistics, the Biden White House aims to accelerate vaccination efforts in the coming months.

Amazon could be well placed to offer help. The company poured $44 billion into its logistics capacity in 2020 alone in an effort to offer one-day shipping for many items.

But there could be potential hurdles in the partnership between tech firms and the new administration. Biden criticized tech companies during his campaign, arguing that Amazon didn’t pay enough taxes. He also signaled his support for antitrust enforcement involving tech companies.

But tech companies have an ongoing campaign to influence the Biden administration, as Reuters has noted.

COVID-19 may prove useful to that end, said Reed Stephens, a partner at the law firm Winston & Strawn LLP. “In addition to the typical goal of U.S. businesses wanting to maintain harmonious relationships with government regulators and congressional sources of oversight, technology companies that are consumer-facing, whether directly or through an extended supply chain, also have strong incentive right now to help the overall effort to bring the pandemic under control,” Stephens said.

“A tech alliance with the federal government fits into the Biden administration’s plan to bring more problem solvers to the table,” added Winston Kirton, also a partner at Winston & Strawn.

Tech companies are a natural ally when it comes to using “data analytics as a tool in the fight against this pandemic and the government’s focus on technology to address the present and any future public health emergencies,” Kirton added.

There are likely other business-related reasons behind the potential alliance between big tech and the U.S. government. Google and Amazon were “already expanding in the life sciences arena well before the pandemic,” Kirton observed.

And tech companies offering help with vaccine distribution can also use the goodwill they develop to drum up business, according to Troy Groetken, a shareholder at the intellectual property law firm with McAndrews, Held & Malloy. “I think the real goal is [tech companies] want to illustrate to the federal government that they can not only be a partner with vaccine distribution, but they can also be a business partner in so many other ways,” Groetken said. “They also want to show they can be good corporate citizens.”

There are pros and cons for such alliances, Groetken stressed. Tech companies could improve efficiencies and trim deployment costs, but such public-private partnerships also can lead to conflicts of interest. “From a regulatory perspective, ethics perspective and conflicts perspective, is this really the best way to go?” Groetken asked. “I think it has to be done very carefully. I think that we have to utilize their systems and so forth for vaccine distribution, but we have to slow ourselves down.”

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at [email protected].

Tell Us What You Think! Cancel reply

Related Articles Read More >

This is the logo of Novartis.
Novartis breaks ground on North Carolina facility
AstraZeneca
AstraZeneca to invest $2B in Maryland, support 2,600 jobs
This is the logo of Novartis.
Novartis opens new manufacturing plant in California
samsung biologics (1)
Samsung Biologics completes Bioepis spinoff to become pure-play pharma CDMO
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE